Accrued expenses consisted of the following (in thousands):
March 31,2025
December 31,2024
Accrued pre-clinical and clinical costs
$
4,096
2,424
Accrued product development costs
390
280
Accrued compensation
999
2,276
Accrued administrative costs
417
446
Total
5,902
5,426
No definition available.
Tabular disclosure of the components of accrued liabilities.